Hjem › Myositt › North Carolina › Durham
Kliniske studier for Myositt i Durham, NC
10 studier for Myositt søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Environmental Risk Factors for the Anti-synthetase Syndrome
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi unna
Adult and Juvenile Myositis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi unna
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekruttererFase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi unna
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RekruttererFase 1
- Research Site, Chapel Hill · 10 mi unna
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RekruttererFase 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi unna
Descartes-08 in Autoantibody Myositis
RekruttererFase 2
- University of North Carolina, Chapel Hill · 10 mi unna
A Study of AZD0120 in Autoimmune Diseases
RekruttererFase 1
- Research Site, Chapel Hill · 10 mi unna
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RekruttererFase 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Duke University Health System, Durham
Myositt-studier i andre byer
- Boston, MA6 studier
- Chicago, IL6 studier
- New York City, NY6 studier
- Houston, TX5 studier
- Miami, FL4 studier
- Cedar Rapids, IA4 studier
- Orange, CA3 studier
- Pittsburgh, PA3 studier
- Baltimore, MD3 studier
- Washington, DC3 studier
- Ann Arbor, MI3 studier
- Jacksonville, FL3 studier
Andre studier i Durham
- Brystkreft64 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.